XML 21 R2.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2019
Dec. 31, 2018
Current Assets:    
Cash and cash equivalents $ 221,771 $ 249,227
Restricted cash 1,503 1,500
Accounts receivable, net 95,398 66,523
Inventory 46,268 57,802
Prepaid and other current assets 7,103 2,945
Total current assets 372,043 377,997
Property, plant and equipment, net 858 63
Operating lease right-of-use asset 8,762  
Other long-term assets 1,102 174
Intangible asset, net 7,157 7,480
TOTAL ASSETS 389,922 385,714
Current Liabilities:    
Accounts payable 34,018 37,632
Accrued expenses and other current liabilities 103,495 84,171
Current portion of long-term debt from royalty-bearing instrument 45,410 34,240
Deferred revenue, current 1,962 1,220
Total current liabilities 184,885 157,263
Long-Term Liabilities:    
Long-term debt from royalty-bearing instrument 23,202 46,108
Deferred revenue, long-term 17,775 19,490
Long-term operating lease liability 8,160  
Other long-term liabilities 6,813 10,523
Total liabilities 240,835 233,384
Commitments and contingencies (Note 6)
Stockholders’ Equity:    
Series A Convertible Preferred Stock, £0.05 par, unlimited authorized; 289,317,460 shares issued and outstanding as of June 30, 2019 and December 31, 2018 (equivalent to 28,931,746 ordinary shares upon future consolidation and redesignation at a 10:1 ratio) 21,850 21,850
Common stock, £0.50 par, unlimited authorized; 335,149,425 issued, 331,307,810 outstanding as of June 30, 2019; 329,110,863 issued, 325,850,013 outstanding as of December 31, 2018 250,588 246,663
Additional paid-in capital 1,311,965 1,282,762
Treasury stock; 3,841,615 shares as of June 30, 2019; 3,260,850 shares as of December 31, 2018 (20,533) (10,413)
Accumulated deficit (1,414,783) (1,388,532)
Total stockholders’ equity 149,087 152,330
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 389,922 $ 385,714